| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 64.21% | 2.24% | -0.08% | 44/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 64.26% | -0.07% | 0.37% | 41/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 64.03% | -4.28% | 5.17% | 41/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 60.88% | -5.24% | -3.06% | 54/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 62.8% | -3.54% | -2.34% | 53/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 64.3% | -0.91% | -3.86% | 48/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 66.89% | -0.1% | 4.11% | 39/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 64.24% | 2.86% | -1.32% | 44/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 65.1% | 4.51% | 0.32% | 41/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 64.9% | 4.5% | -3.07% | 44/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 66.95% | 5.1% | 7.2% | 37/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 62.46% | 2.38% | 0.26% | 47/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 62.29% | -0.4% | 0.31% | 47/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 62.1% | -1.06% | -2.52% | 50/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 63.7% | -1.83% | 4.42% | 46/132 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 61.01% | -8.93% | -2.46% | 63/132 | 57.29% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 62.54% | -10.32% | -0.35% | 51/132 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 62.76% | -11.42% | -3.27% | 57/132 | 58.42% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 64.89% | -11.95% | -3.13% | 47/132 | 60.75% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 66.99% | -7.25% | -3.95% | 48/132 | 59.59% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 69.74% | -4% | -1.58% | 30/132 | 61.59% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 70.86% | -3.35% | -3.85% | 32/132 | 59.94% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 73.69% | -0.08% | 2.03% | 21/132 | 58.33% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 72.23% | -0.72% | -0.57% | 31/132 | 56.37% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 72.64% | -0.95% | -0.91% | 15/132 | 55.22% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 73.31% | 0.71% | -0.6% | 20/132 | 57.37% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 73.75% | 1.66% | 1.38% | 10/132 | 52.04% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 72.75% | 8.21% | -0.8% | 30/132 | 55.53% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 73.34% | 10.66% | 0.74% | 12/132 | 51.47% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 72.8% | 12.64% | 0.34% | 13/132 | 51.56% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 72.55% | 14.21% | 7.91% | 10/132 | 50.98% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 67.23% | 10.31% | 1.45% | 36/132 | 55.34% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 66.27% | 9.49% | 2.55% | 16/132 | 52.35% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 64.62% | 7.49% | 1.73% | 21/132 | 53.87% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 63.53% | 9.48% | 4.22% | 17/132 | 52.96% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 60.95% | 10.17% | 0.69% | 35/132 | 56.43% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 60.53% | 11.11% | 0.68% | 13/132 | 50.39% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 60.12% | 12.25% | 3.62% | 19/132 | 51.46% | 明德生物 | 86.71% | 行业排名> |
| 2016-03-31 | 58.02% | 10.57% | 4.88% | 11/132 | 48.15% | 健帆生物 | 83.86% | 行业排名> |
| 2015-12-31 | 55.32% | -12.94% | 1.56% | 28/132 | 53.26% | 正海生物 | 94.02% | 行业排名> |
| 2015-09-30 | 54.48% | -14.14% | 1.71% | 12/132 | 47.96% | 冠昊生物 | 84.57% | 行业排名> |
| 2015-06-30 | 53.56% | -15.43% | 2.06% | 20/132 | 51.86% | 艾德生物 | 94.5% | 行业排名> |
| 2015-03-31 | 52.48% | -18.24% | -17.42% | 14/132 | 48.84% | 基蛋生物 | 85.13% | 行业排名> |

微信公众号
证券之星APP



